Zhi‐Jun Pei

948 total citations
51 papers, 699 citations indexed

About

Zhi‐Jun Pei is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Zhi‐Jun Pei has authored 51 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Zhi‐Jun Pei's work include RNA modifications and cancer (25 papers), Ferroptosis and cancer prognosis (14 papers) and Cancer-related molecular mechanisms research (12 papers). Zhi‐Jun Pei is often cited by papers focused on RNA modifications and cancer (25 papers), Ferroptosis and cancer prognosis (14 papers) and Cancer-related molecular mechanisms research (12 papers). Zhi‐Jun Pei collaborates with scholars based in China, United States and Taiwan. Zhi‐Jun Pei's co-authors include Yan Gao, Xu‐Sheng Liu, Fuyan Li, Hong Zhou, Xiaoyu Liu, Lingling Yuan, Yijia Chen, Yafeng Song, Jing Zeng and Yi Yang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Annals of Oncology.

In The Last Decade

Zhi‐Jun Pei

50 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhi‐Jun Pei China 15 495 299 171 127 71 51 699
Kaori Koga Japan 16 379 0.8× 135 0.5× 184 1.1× 264 2.1× 92 1.3× 54 807
Xinzhong Li China 16 853 1.7× 567 1.9× 62 0.4× 95 0.7× 165 2.3× 28 1.1k
Yanhui Zhang China 14 671 1.4× 591 2.0× 50 0.3× 86 0.7× 65 0.9× 26 910
Mengwei Wu China 12 385 0.8× 270 0.9× 163 1.0× 202 1.6× 63 0.9× 27 682
Daiki Taniyama Japan 14 277 0.6× 123 0.4× 108 0.6× 267 2.1× 66 0.9× 46 527
Lu Zang China 12 716 1.4× 448 1.5× 111 0.6× 216 1.7× 69 1.0× 26 923
Cun Wang China 13 239 0.5× 110 0.4× 95 0.6× 258 2.0× 118 1.7× 30 653
Cheng Zhou China 17 583 1.2× 436 1.5× 145 0.8× 250 2.0× 116 1.6× 51 1.1k
Guixiong Fan China 14 553 1.1× 381 1.3× 322 1.9× 221 1.7× 32 0.5× 33 824

Countries citing papers authored by Zhi‐Jun Pei

Since Specialization
Citations

This map shows the geographic impact of Zhi‐Jun Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Jun Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Jun Pei more than expected).

Fields of papers citing papers by Zhi‐Jun Pei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi‐Jun Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Jun Pei. The network helps show where Zhi‐Jun Pei may publish in the future.

Co-authorship network of co-authors of Zhi‐Jun Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi‐Jun Pei. A scholar is included among the top collaborators of Zhi‐Jun Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi‐Jun Pei. Zhi‐Jun Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Xu‐Sheng, Yuxuan Chen, Yangyang Wang, et al.. (2024). TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. Scientific Reports. 14(1). 4042–4042. 8 indexed citations
3.
Pei, Zhi‐Jun, et al.. (2023). Wide and deep cross network for the rate of penetration prediction. Geoenergy Science and Engineering. 229. 212066–212066. 5 indexed citations
4.
Zhang, Yaohua, Xu‐Sheng Liu, Yan Gao, et al.. (2023). SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with 18F-FDG metabolic parameters. Lung Cancer. 188. 107449–107449. 5 indexed citations
5.
Liu, Xu‐Sheng, Lingling Yuan, Yan Gao, et al.. (2023). DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma. Journal of Translational Medicine. 21(1). 574–574. 5 indexed citations
6.
Gao, Yan, Lingling Yuan, Changbin Ke, et al.. (2023). Caprin-1 plays a role in cell proliferation and Warburg metabolism of esophageal carcinoma by regulating METTL3 and WTAP. Journal of Translational Medicine. 21(1). 159–159. 10 indexed citations
7.
Liu, Xu‐Sheng, Yan Gao, Xueqin Chen, et al.. (2022). Comprehensive Analysis of YTHDF1 Immune Infiltrates and ceRNA in Human Esophageal Carcinoma. Frontiers in Genetics. 13. 835265–835265. 21 indexed citations
8.
Liu, Xu‐Sheng, Jing Zeng, Xueqin Chen, et al.. (2022). SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA. Frontiers in Cell and Developmental Biology. 10. 853596–853596. 35 indexed citations
9.
Gao, Yan, Lingling Yuan, Jing Zeng, et al.. (2022). eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma. Journal of Translational Medicine. 20(1). 303–303. 10 indexed citations
10.
Zhang, Yaohua, Jing Zeng, Xu‐Sheng Liu, et al.. (2022). ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma. Frontiers in Endocrinology. 13. 1013238–1013238. 5 indexed citations
11.
Gao, Yan, Xu‐Sheng Liu, Jing Zeng, et al.. (2022). Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma. Frontiers in Oncology. 12. 809847–809847. 6 indexed citations
12.
Gao, Yan, et al.. (2022). Metabolic assessment of cerebral palsy with normal clinical MRI using 18F-FDG PET imaging: A preliminary report. Frontiers in Neurology. 13. 844911–844911. 3 indexed citations
13.
Liu, Xiaoyu, Yan Gao, Xu‐Sheng Liu, et al.. (2022). High expression of HNRNPR in ESCA combined with 18F-FDG PET/CT metabolic parameters are novel biomarkers for preoperative diagnosis of ESCA. Journal of Translational Medicine. 20(1). 450–450. 6 indexed citations
14.
Yuan, Lingling, Yan Gao, Xu‐Sheng Liu, et al.. (2021). 18F-FDG PET/CT metabolic parameters correlate with EIF2S2 expression status in colorectal cancer. Journal of Cancer. 12(19). 5838–5847. 9 indexed citations
15.
Liu, Xu‐Sheng, Yan Gao, Libing Wu, et al.. (2021). Comprehensive Analysis of GLUT1 Immune Infiltrates and ceRNA Network in Human Esophageal Carcinoma. Frontiers in Oncology. 11. 665388–665388. 27 indexed citations
16.
Liu, Xu‐Sheng, Yijia Chen, Fuyan Li, et al.. (2021). Comprehensive Analysis of Hexokinase 2 Immune Infiltrates and m6A Related Genes in Human Esophageal Carcinoma. Frontiers in Cell and Developmental Biology. 9. 715883–715883. 14 indexed citations
17.
18.
Yuan, Lingling, et al.. (2020). Nucleophosmin 1 overexpression correlates with 18F-FDG PET/CT metabolic parameters and improves diagnostic accuracy in patients with lung adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 48(3). 904–912. 12 indexed citations
19.
Pei, Zhi‐Jun, Jing Zeng, Yan Gao, et al.. (2016). Oxymatrine inhibits the proliferation of CaSki cells via downregulating HPV16E7 expression. Oncology Reports. 36(1). 291–298. 14 indexed citations
20.
Pei, Zhi‐Jun, Xiaoli Lan, Zhen Cheng, et al.. (2014). Multimodality Molecular Imaging to Monitor Transplanted Stem Cells for the Treatment of Ischemic Heart Disease. PLoS ONE. 9(3). e90543–e90543. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaori Koga Breakdown of academic impact, for papers by Xinzhong Li Breakdown of academic impact, for papers by Yanhui Zhang Breakdown of academic impact, for papers by Mengwei Wu Breakdown of academic impact, for papers by Daiki Taniyama Breakdown of academic impact, for papers by Lu Zang Breakdown of academic impact, for papers by Cun Wang Breakdown of academic impact, for papers by Cheng Zhou Breakdown of academic impact, for papers by Guixiong Fan
Rankless by CCL
2026